These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 28092395

  • 1. Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.
    Karl MD, Francis JH, Iyer S, Marr B, Abramson DH.
    J Pediatr Ophthalmol Strabismus; 2017 May 01; 54(3):185-190. PubMed ID: 28092395
    [Abstract] [Full Text] [Related]

  • 2. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL, Alset AE, Say EA, Caywood E, Jabbour P, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2016 Sep 01; 53(5):275-84. PubMed ID: 27486728
    [Abstract] [Full Text] [Related]

  • 3. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R.
    JAMA Ophthalmol; 2014 Aug 01; 132(8):936-41. PubMed ID: 24789622
    [Abstract] [Full Text] [Related]

  • 4. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL, Douglass AM, Beggache M, Say EA, Shields JA.
    Retina; 2016 Jun 01; 36(6):1184-90. PubMed ID: 26630319
    [Abstract] [Full Text] [Related]

  • 5. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
    Kiratli H, Koç I, Öztürk E, Varan A, Akyüz C.
    Jpn J Ophthalmol; 2020 Jul 01; 64(4):351-358. PubMed ID: 32447585
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
    Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA.
    JAMA Ophthalmol; 2014 Mar 01; 132(3):319-25. PubMed ID: 24407202
    [Abstract] [Full Text] [Related]

  • 7. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC.
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb 01; 254(2):391-4. PubMed ID: 26511530
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH, Brodie SE, Marr B, Zabor EC, Mondesire-Crump I, Abramson DH.
    Ophthalmology; 2017 Apr 01; 124(4):488-495. PubMed ID: 28089679
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
    Lawson BM, Saktanasate J, Say EA, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2014 Dec 12; 51 Online():e92-4. PubMed ID: 25490242
    [Abstract] [Full Text] [Related]

  • 10. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW.
    Ophthalmology; 2017 Dec 12; 124(12):1817-1825. PubMed ID: 28655537
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB, Hui P, Punyara K, Bi MC, Li SH, Teng SY, Song E.
    Chin Med J (Engl); 2013 Dec 12; 126(8):1587. PubMed ID: 23595400
    [No Abstract] [Full Text] [Related]

  • 12. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada GL, Abramson DH.
    Ophthalmology; 2014 Sep 12; 121(9):1810-7. PubMed ID: 24819859
    [Abstract] [Full Text] [Related]

  • 13. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
    Francis JH, Marr BP, Brodie SE, Gobin YP, Abramson DH.
    JAMA Ophthalmol; 2014 Aug 12; 132(8):1024-5. PubMed ID: 25124953
    [No Abstract] [Full Text] [Related]

  • 14. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H, Koç İ, Varan A, Akyüz C.
    Eur J Ophthalmol; 2017 Jun 26; 27(4):423-427. PubMed ID: 28106239
    [Abstract] [Full Text] [Related]

  • 15. Spectral Domain Optical Coherence Tomography Reveals Hidden Fovea Beneath Extensive Vitreous Seeding From Retinoblastoma.
    Hasanreisoglu M, Dolz-Marco R, Ferenczy SR, Shields JA, Shields CL.
    Retina; 2015 Jul 26; 35(7):1486-7. PubMed ID: 25756924
    [No Abstract] [Full Text] [Related]

  • 16. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F, Shields CL.
    Arch Ophthalmol; 2012 Oct 26; 130(10):1268-71. PubMed ID: 23044940
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
    Bogan CM, Kaczmarek JV, Pierce JM, Chen SC, Boyd KL, Calcutt MW, Bridges TM, Lindsley CW, Nadelmann JB, Liao A, Hsieh T, Abramson DH, Francis JH, Friedman DL, Richmond A, Daniels AB.
    Br J Ophthalmol; 2022 Feb 26; 106(2):288-296. PubMed ID: 33972235
    [Abstract] [Full Text] [Related]

  • 18. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH, Abramson DH, Gaillard MC, Marr BP, Beck-Popovic M, Munier FL.
    Ophthalmology; 2015 Jun 26; 122(6):1173-9. PubMed ID: 25795478
    [Abstract] [Full Text] [Related]

  • 19. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
    De Francesco S, Galluzzi P, Bracco S, Menicacci F, Motolese E, Hadjistilianou T.
    Int Ophthalmol; 2015 Dec 26; 35(6):887-95. PubMed ID: 26416040
    [Abstract] [Full Text] [Related]

  • 20. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E, Del Sole MJ, Torbidoni A, Fandino A, Asprea M, Croxatto JO, Chantada GL, Bramuglia GF, Schaiquevich P.
    Exp Eye Res; 2013 Mar 26; 108():103-9. PubMed ID: 23333535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.